When Recurrent Diarrhea Is More Than a Passing Bug: The Rising Threat of IBD in Young Adults
When recurring abdominal pain and diarrhea strike, most people first assume they are dealing with a standard bout of gastroenteritis or irritable...
Search results for "cell therapy"
Seizure- and Recurrence-Prone Glioma: First New Drug in 20 Years
Being diagnosed with a brain tumor in your 30s or 40s—when you are building your career, raising children, and staying socially active—can upend your...
Korean Researchers Uncover New Clues to Enhance Chronic Myeloid Leukemia Treatment
Korean researchers have uncovered a biological mechanism that could significantly improve the efficacy of treatments...
Osteoporosis Drugs That Can Be Hard to Keep Taking…Could ‘Sleeping Bone Cells’ Offer a Breakthrough?
Some patients need to rebuild bone quickly. These are people at high fracture risk—those who have already broken a bone...
30 Specialized Surgeons, Zero Ego: The Daily Morning Debates Shaping Excellence at Bucheon Yeson Hospital
“After the right-thumb replantation surgery, I’ll treat the patient using this specific method.
Can 'Sound and Light' Treat the Brain? New Hope for Dementia Therapy Without Side Effects
A South Korean research team has demonstrated the potential for treating Alzheimer’s disease using non-invasive sound...
Rznomics and Inha University Confirm Potential for In-Vivo CAR-T Delivery Technology
Rznomics announced on the 30th that a joint study with Professor Hyun-jin Kim’s research team at Inha University has...
Will Curocell’s First CAR-T Blood Cancer Drug Secure Approval Next Month?
A final decision on the approval of RIMQARTO (anbalcabtagene autoleucel), a chimeric antigen receptor T-cell (CAR-T)...
Celltrion Secures Japanese Approval for Xolair and Eylea Biosimilars
Celltrion announced on the 27th that it has obtained marketing authorization from Japan’s Ministry of Health, Labour...
A Single Cancer Shot: Local Injection Triggers Systemic Tumor Disappearance
For decades, one immuno-oncology strategy has held immense promise while repeatedly falling short: the use of CD40...